메뉴 건너뛰기




Volumn 37, Issue 2, 2005, Pages 923-926

Reversal of acute cellular rejection after renal transplantation with Campath-1H

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIBODY; CREATININE; DIPHENHYDRAMINE; FAMOTIDINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PARACETAMOL; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; VALGANCICLOVIR;

EID: 17844363736     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.019     Document Type: Conference Paper
Times cited : (53)

References (15)
  • 1
    • 0028800590 scopus 로고
    • Successful treatment of renal allograft rejection with a humanized antilymphocytic monoclonal antibody
    • P.J. Friend, P. Rebello, D. Oliviera Successful treatment of renal allograft rejection with a humanized antilymphocytic monoclonal antibody Transplant Proc 27 1995 869
    • (1995) Transplant Proc , vol.27 , pp. 869
    • Friend, P.J.1    Rebello, P.2    Oliviera, D.3
  • 2
    • 17844374542 scopus 로고    scopus 로고
    • Successful reversal of refractory acute rejection with Campath 1H in pancreas transplant recipients(abstract)
    • S. Potdar, R. Shapiro, N. Thai Successful reversal of refractory acute rejection with Campath 1H in pancreas transplant recipients(abstract) Am J Transplant 3 s5 2003 324
    • (2003) Am J Transplant , vol.3 , Issue.5 S , pp. 324
    • Potdar, S.1    Shapiro, R.2    Thai, N.3
  • 3
    • 0037183898 scopus 로고    scopus 로고
    • Treatment of refractory acute rejection in a lung transplant recipient with Campath 1H
    • B.D. Reams, R.D. Davis, J. Curl Treatment of refractory acute rejection in a lung transplant recipient with Campath 1H Transplantation 74 6 2002 903
    • (2002) Transplantation , vol.74 , Issue.6 , pp. 903
    • Reams, B.D.1    Davis, R.D.2    Curl, J.3
  • 4
    • 3543001679 scopus 로고    scopus 로고
    • Steroid- and ATG-resistant rejection after double forearm transplantation responds to Campath 1H
    • S. Schneeberger, A. Kreczy, G. Brandacher Steroid- and ATG-resistant rejection after double forearm transplantation responds to Campath 1H Am J Transplant 4 2004 1372
    • (2004) Am J Transplant , vol.4 , pp. 1372
    • Schneeberger, S.1    Kreczy, A.2    Brandacher, G.3
  • 5
    • 0023911111 scopus 로고
    • Reshaping human antibodies for therapy
    • L. Riechmann, M. Mark, H. Waldmann Reshaping human antibodies for therapy Nature 332 1988 323
    • (1988) Nature , vol.332 , pp. 323
    • Riechmann, L.1    Mark, M.2    Waldmann, H.3
  • 6
    • 0038578245 scopus 로고    scopus 로고
    • Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: Relevance for early adoptive immunotherapy and infectious complications
    • E.C. Morris, P. Rebello, K.J. Thomson Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications Blood 102 1 2003 404
    • (2003) Blood , vol.102 , Issue.1 , pp. 404
    • Morris, E.C.1    Rebello, P.2    Thomson, K.J.3
  • 7
    • 0024566393 scopus 로고
    • Effects of Campath 1H antibodies in vivo in patients with lymphoid malignancies: Influence of antibody isotype
    • M.J. Dyer, G. Hale, F.G. Hayhoe Effects of Campath 1H antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype Blood 73 1989 1431
    • (1989) Blood , vol.73 , pp. 1431
    • Dyer, M.J.1    Hale, G.2    Hayhoe, F.G.3
  • 8
    • 0029852737 scopus 로고    scopus 로고
    • A therapeutic IgG4 monoclonal antibody that depletes target cells in humans
    • J.D. Isaacs, J.G. Wing, J.D. Greenwood A therapeutic IgG4 monoclonal antibody that depletes target cells in humans Clin Exp Immunol 106 1996 427
    • (1996) Clin Exp Immunol , vol.106 , pp. 427
    • Isaacs, J.D.1    Wing, J.G.2    Greenwood, J.D.3
  • 9
    • 0038805159 scopus 로고    scopus 로고
    • Campath 1H induction plus Rapamycin monotherapy for renal transplantation: Results of a pilot study
    • S.J. Knechtle, J.D. Pirsch, J.H. Fechner Jr Campath 1H induction plus Rapamycin monotherapy for renal transplantation: results of a pilot study Am J Transplant 3 2003 722
    • (2003) Am J Transplant , vol.3 , pp. 722
    • Knechtle, S.J.1    Pirsch, J.D.2    Fechner Jr., J.H.3
  • 10
    • 0031838098 scopus 로고    scopus 로고
    • A randomized prospective study comparing low dose OKT3 to low dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients
    • C. Mariat, E. Alamartine, N. Diab A randomized prospective study comparing low dose OKT3 to low dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients Transpl Int 11 1998 231
    • (1998) Transpl Int , vol.11 , pp. 231
    • Mariat, C.1    Alamartine, E.2    Diab, N.3
  • 11
    • 0030859743 scopus 로고    scopus 로고
    • ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation
    • A. Uslu, Y. Tokat, E. Ok ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation Transplant Proc 29 1997 2805
    • (1997) Transplant Proc , vol.29 , pp. 2805
    • Uslu, A.1    Tokat, Y.2    Ok, E.3
  • 12
    • 0345676502 scopus 로고    scopus 로고
    • Results of the Double-blind, randomized, multicenter phase III clinical trial of Thymoglobulin versus ATGAM in the treatment of acute graft rejection episodes after renal transplantation
    • A.O. Gaber, M.R. First, R.J. Tesi Results of the Double-blind, randomized, multicenter phase III clinical trial of Thymoglobulin versus ATGAM in the treatment of acute graft rejection episodes after renal transplantation Transplantation 66 1998 29
    • (1998) Transplantation , vol.66 , pp. 29
    • Gaber, A.O.1    First, M.R.2    Tesi, R.J.3
  • 13
    • 0031860757 scopus 로고    scopus 로고
    • Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation
    • L. Rostaing, M.H. Chabannier, A. Modesto Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation Transplant Proc 30 1998 1170
    • (1998) Transplant Proc , vol.30 , pp. 1170
    • Rostaing, L.1    Chabannier, M.H.2    Modesto, A.3
  • 14
    • 0035881990 scopus 로고    scopus 로고
    • Reversal of steroid and antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant patients
    • P.P. Luke, M.L. Jordan, V.P. Scantlebury Reversal of steroid and antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant patients Transplantation 72 3 2001 419
    • (2001) Transplantation , vol.72 , Issue.3 , pp. 419
    • Luke, P.P.1    Jordan, M.L.2    Scantlebury, V.P.3
  • 15
    • 0035863090 scopus 로고    scopus 로고
    • A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection
    • D.H. Casadei, M. del C. Rial, G. Opelz A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection Transplantation 71 1 2001 53
    • (2001) Transplantation , vol.71 , Issue.1 , pp. 53
    • Casadei, D.H.1    Del Rial, C.M.2    Opelz, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.